We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$226M
AUM Growth
-$6.22M
Cap. Flow
-$8.11M
Cap. Flow %
-3.58%
Top 10 Hldgs %
39.35%
Holding
60
New
1
Increased
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$600K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$4.74M
2
STKL
SunOpta
STKL
+$3.01M
3
JNJ icon
Johnson & Johnson
JNJ
+$337K
4
MA icon
Mastercard
MA
+$49.2K
5
TGT icon
Target
TGT
+$48.9K

Sector Composition

Rank Sector Weight
1 Healthcare 26.52%
2 Industrials 24.75%
3 Consumer Staples 13.96%
4 Technology 13.36%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
51
Adobe
ADBE
$116B
$927K 0.41%
9,000
DELL icon
52
Dell
DELL
$295B
$806K 0.36%
52,230
ADNT icon
53
Adient
ADNT
$1.47B
$665K 0.29%
+11,357
New +$600K
CDK
54
DELISTED
CDK Global, Inc.
CDK
$647K 0.29%
10,833
KO icon
55
Coca-Cola
KO
$386B
$337K 0.15%
8,131
CVX icon
56
Chevron
CVX
$396B
$291K 0.13%
2,472
NVS icon
57
Novartis
NVS
$292B
$259K 0.11%
3,979
-73,098
-95% -$4.74M
IVV icon
58
iShares Core S&P 500 ETF
IVV
$898B
$256K 0.11%
1,140
CNI icon
59
Canadian National Railway
CNI
$76.2B
$248K 0.11%
3,675
-675
-16% -$44.6K
STKL
60
DELISTED
SunOpta
STKL
-425,950
Closed -$3.01M

Similar funds

Chad R. Baker's Q4 2016 Portfolio in Review

As of Q4 2016, Chad R. Baker held 60 positions worth $226M, down 2.7% from $233M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker withdrew a net $8.11M in Q4 2016, closing 1 position and reducing 20 holdings. Its most notable exit was SunOpta, an estimated $3.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Chad R. Baker opened a new position in Adient worth $665K.

  • Chad R. Baker's largest Q4 2016 buy was Adient: 11,357 shares worth $665K.
  • Chad R. Baker's biggest Q4 2016 reduction was Novartis, cutting an estimated $4.74M.
  • Chad R. Baker fully exited SunOpta in Q4 2016, selling an estimated $3.01M.
  • Chad R. Baker's ten largest holdings make up 39% of its $226M portfolio in Q4 2016.
  • Chad R. Baker opened 1 new position and closed 1 in Q4 2016.
  • Chad R. Baker's portfolio value fell 2.7% quarter-over-quarter to $226M.

Based on Chad R. Baker's 13F filing for Q4 2016, filed 3 Feb 2017.